Stephen R. Holdsworth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stephen R. Holdsworth has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Arthur Richard Kitching
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria 3168, Australia
10 shared publications Peter G. Tipping
Monash University
6 shared publications- Joshua D. Ooi
Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia
4 shared publications Amanda-Jane Ruth
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC 3168, Australia
3 shared publicationsDragana Odobasic
Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia
3 shared publicationsTimothy J. Semple
Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia
3 shared publications
Latest Publications
- 3 November 2014
- Published by Wiley in Current Protocols in Immunology
- Vol. 107 (1) , 15.27.1-15.27.19
T Cell Mediated Autoimmune Glomerular Disease in Mice
Many forms of glomerulonephritis are mediated by autoimmunity. While autoantibodies are often pathogenic, cell‐mediated immunity plays an important role in a number of forms of rapidly progressive glomerulonephritis. This unit describes the induction of cell‐mediated autoimmune glomerular disease in mice. One disease model, experimental anti‐glomerular basement membrane (GBM) disease, features autoreactivity to a well‐defined component of type IV collagen found in the GBM, α3(IV)NC1. The other models the cell‐mediated effector response in forms of renal vasculitis, where autoantibodies to myeloperoxidase result in systemic neutrophil activation, resulting in their localization to the glomerulus and the subsequent deposition of myeloperoxidase within glomerular capillaries. There, myeloperoxidase acts as a “planted” autoantigen and is recognized by effector autoreactive myeloperoxidase‐specific T cells. These models are useful both in defining mechanisms germane to the development of autoimmunity to α3(IV)NC1 and myeloperoxidase, and in dissecting the role of cell‐mediated responses in effecting glomerular injury. © 2014 by John Wiley & Sons, Inc. Keywords: glomerulonephritis; autoimmunity; cell‐mediated immunity; T lymphocytes
- 3 November 2014
- Published by Wiley in Current Protocols in Immunology
- Vol. 107 (1) , 15.27.1-15.27.19
T Cell Mediated Autoimmune Glomerular Disease in Mice
Many forms of glomerulonephritis are mediated by autoimmunity. While autoantibodies are often pathogenic, cell‐mediated immunity plays an important role in a number of forms of rapidly progressive glomerulonephritis. This unit describes the induction of cell‐mediated autoimmune glomerular disease in mice. One disease model, experimental anti‐glomerular basement membrane (GBM) disease, features autoreactivity to a well‐defined component of type IV collagen found in the GBM, α3(IV)NC1. The other models the cell‐mediated effector response in forms of renal vasculitis, where autoantibodies to myeloperoxidase result in systemic neutrophil activation, resulting in their localization to the glomerulus and the subsequent deposition of myeloperoxidase within glomerular capillaries. There, myeloperoxidase acts as a “planted” autoantigen and is recognized by effector autoreactive myeloperoxidase‐specific T cells. These models are useful both in defining mechanisms germane to the development of autoimmunity to α3(IV)NC1 and myeloperoxidase, and in dissecting the role of cell‐mediated responses in effecting glomerular injury. © 2014 by John Wiley & Sons, Inc. Keywords: glomerulonephritis; autoimmunity; cell‐mediated immunity; T lymphocytes
- 1 November 2010
- Published by Oxford University Press (OUP)
- p. 105-128
Pathways of cellular adaptive immunity in autoimmune crescentic glomerulonephritis and lupus nephritis
- 1 November 2010
- Published by Oxford University Press (OUP)
- p. 105-128
Pathways of cellular adaptive immunity in autoimmune crescentic glomerulonephritis and lupus nephritis
- 23 July 2010
- Published by Wiley in Nephrology
- Vol. 15 (5) , 513-521
Review: T helper 17 cells: Their role in glomerulonephritis
T helper (Th) cells are an integral part of the host's immune response to eliminate invading pathogens. However, autoimmune or ‘autoinflammatory’ diseases can develop if Th cell responses are not effectively regulated. Several subsets of Th cells exist, including the Th17 subset that produces interleukin‐17A, important in experimental models of organ‐specific autoimmune inflammation. Its discovery has explained paradoxical observations in model systems thought to be Th1 mediated but were exacerbated in the absence of interferon‐γ, the prototypic Th1 effector cytokine. Th17 cells express unique transcription factors and secrete a unique pattern of cytokines. Interleukin‐17A induces pro‐inflammatory cytokines and chemokines and mediates neutrophil recruitment. Th17 cells have a reciprocal relationship with T regulatory cells and can also mediate suppression of Th1 responses. Recent studies also suggest that Th17 cells are not terminally differentiated but can switch into Th1 cells. Th17 cells have themselves been recently shown to induce antigen‐specific cell‐mediated proliferative glomerulonephritis. There is increasing evidence implicating Th17 cells in anti‐glomerular basement membrane disease, lupus nephritis and pauci‐immune glomerulonephritis. This review will review the discovery of the Th17 subset, its properties, its relationship with other Th subsets and assess the current evidence implicating Th17 cells in glomerulonephritis.
- 23 July 2010
- Published by Wiley in Nephrology
- Vol. 15 (5) , 513-521
Review: T helper 17 cells: Their role in glomerulonephritis
T helper (Th) cells are an integral part of the host's immune response to eliminate invading pathogens. However, autoimmune or ‘autoinflammatory’ diseases can develop if Th cell responses are not effectively regulated. Several subsets of Th cells exist, including the Th17 subset that produces interleukin‐17A, important in experimental models of organ‐specific autoimmune inflammation. Its discovery has explained paradoxical observations in model systems thought to be Th1 mediated but were exacerbated in the absence of interferon‐γ, the prototypic Th1 effector cytokine. Th17 cells express unique transcription factors and secrete a unique pattern of cytokines. Interleukin‐17A induces pro‐inflammatory cytokines and chemokines and mediates neutrophil recruitment. Th17 cells have a reciprocal relationship with T regulatory cells and can also mediate suppression of Th1 responses. Recent studies also suggest that Th17 cells are not terminally differentiated but can switch into Th1 cells. Th17 cells have themselves been recently shown to induce antigen‐specific cell‐mediated proliferative glomerulonephritis. There is increasing evidence implicating Th17 cells in anti‐glomerular basement membrane disease, lupus nephritis and pauci‐immune glomerulonephritis. This review will review the discovery of the Th17 subset, its properties, its relationship with other Th subsets and assess the current evidence implicating Th17 cells in glomerulonephritis.
- 1 June 2010
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (6) , 925-931
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis
A major target autoantigen in anti-neutrophil cytoplasmic antibody–associated vasculitis is myeloperoxidase (MPO). Although MPO-specific CD4+ Th cells seem to orchestrate renal injury, the role of the Th17 subset is unknown. We hypothesized that Th17 cells direct injurious anti-MPO autoimmunity in experimental murine anti-MPO–induced glomerulonephritis (GN). We immunized mice with MPO to establish autoimmunity, resulting in systemic IL-17A production with MPO-specific dermal delayed-type hypersensitivity. We triggered disease using antibodies to the glomerular basement membrane to induce glomerular deposition of MPO by neutrophils. Wild-type mice developed necrotizing GN with an influx of glomerular leukocytes and albuminuria. In contrast, mice deficient in the key Th17 effector cytokine IL-17A were nearly completely protected. The protective effects resulted partly from reduced neutrophil recruitment, which led to less disposition of glomerular MPO. To test whether IL-17A also drives autoimmune delayed-type hypersensitivity in the kidney, we injected MPO into the kidneys of MPO-sensitized mice. IL-17A deficiency reduced accumulation of renal macrophages and renal CCL5 mRNA expression. In conclusion, IL-17A contributes to the pathophysiology of autoimmune anti-MPO GN, suggesting that it may be a viable therapeutic target for this disease.
- 1 June 2010
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (6) , 925-931
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis
A major target autoantigen in anti-neutrophil cytoplasmic antibody–associated vasculitis is myeloperoxidase (MPO). Although MPO-specific CD4+ Th cells seem to orchestrate renal injury, the role of the Th17 subset is unknown. We hypothesized that Th17 cells direct injurious anti-MPO autoimmunity in experimental murine anti-MPO–induced glomerulonephritis (GN). We immunized mice with MPO to establish autoimmunity, resulting in systemic IL-17A production with MPO-specific dermal delayed-type hypersensitivity. We triggered disease using antibodies to the glomerular basement membrane to induce glomerular deposition of MPO by neutrophils. Wild-type mice developed necrotizing GN with an influx of glomerular leukocytes and albuminuria. In contrast, mice deficient in the key Th17 effector cytokine IL-17A were nearly completely protected. The protective effects resulted partly from reduced neutrophil recruitment, which led to less disposition of glomerular MPO. To test whether IL-17A also drives autoimmune delayed-type hypersensitivity in the kidney, we injected MPO into the kidneys of MPO-sensitized mice. IL-17A deficiency reduced accumulation of renal macrophages and renal CCL5 mRNA expression. In conclusion, IL-17A contributes to the pathophysiology of autoimmune anti-MPO GN, suggesting that it may be a viable therapeutic target for this disease.
- 1 December 2008
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (12) , 2254-2261
Role of Mast Cells in Progressive Renal Diseases
Advances in understanding mast cell biology reveal their diverse functional capacity well beyond already established roles in host defense against parasites and allergic disease. Mast cells can initiate, amplify, and direct innate and adaptive immune responses. They also modulate inflammation and regulate immunity. Mast cells potentially induce tissue repair and direct fibrosis; however, they also play other roles in tissue remodeling and repair. Various activation and differentiating signals result in a diverse range of functional phenotypes called "mast cell heterogeneity." Mast cells are significant participants in chronic progressive kidney disease, and their presence is associated with function loss and fibrosis. This suggests a potential role in the fibrotic process, which may involve mast cell activation of local renin-angiotensin systems. Experimental animal studies suggest, however, they do not directly cause renal fibrosis but rather spark inflammation. Evidence for both pro- and anti-inflammatory roles in nephritis is emerging.
- 1 December 2008
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (12) , 2254-2261
Role of Mast Cells in Progressive Renal Diseases
Advances in understanding mast cell biology reveal their diverse functional capacity well beyond already established roles in host defense against parasites and allergic disease. Mast cells can initiate, amplify, and direct innate and adaptive immune responses. They also modulate inflammation and regulate immunity. Mast cells potentially induce tissue repair and direct fibrosis; however, they also play other roles in tissue remodeling and repair. Various activation and differentiating signals result in a diverse range of functional phenotypes called "mast cell heterogeneity." Mast cells are significant participants in chronic progressive kidney disease, and their presence is associated with function loss and fibrosis. This suggests a potential role in the fibrotic process, which may involve mast cell activation of local renin-angiotensin systems. Experimental animal studies suggest, however, they do not directly cause renal fibrosis but rather spark inflammation. Evidence for both pro- and anti-inflammatory roles in nephritis is emerging.
- Open Access
- 10 July 2008
- Published by Wiley in Immunology
- Vol. 124 (4) , 503-513
Distinct in vivo roles of CD80 and CD86 in the effector T‐cell responses inducing antigen‐induced arthritis
Summary: CD80 and CD86 play a critical role in the initiation of T‐cell responses. However, their role in the in vivo effector CD4+ T‐cell responses has been less extensively investigated. The current studies have examined the functional relevance of CD80 and CD86 in the effector CD4+ T‐cell responses inducing antigen‐induced arthritis. Arthritis was induced in C57BL/6 mice by sensitization to methylated bovine serum albumin (mBSA) on day 0, booster immunization (day 7) and intra‐articular injection of mBSA (day 21). Control or anti‐CD80 and/or anti‐CD86 monoclonal antibodies were administered from day 21 to day 28. Arthritis severity and immune responses were assessed on day 28. The development of arthritis was significantly suppressed by inhibition of CD80 or CD86. Blockade of both CD80 and CD86 caused a trend towards reduced disease severity compared to control antibody‐treated mice. Neutralization of CD80 attenuated accumulation of CD4+ T cells in joints and enhanced splenocyte production and circulating levels of interleukin‐4. Inhibition of CD86 or both CD80 and CD86 reduced T‐cell accumulation in joints without affecting T helper type 1/type 2 (Th1/Th2) differentiation or antibody levels. Blockade of CD86, and not CD80, significantly suppressed splenocyte interleukin‐17 (IL‐17) production. These results provide further in vivo evidence that CD80 and CD86 play important pathogenic roles in effector T‐cell responses. CD80 exacerbates arthritis by downregulating systemic levels of IL‐4 and increasing T‐cell accumulation in joints without affecting IL‐17 production. CD86 enhances disease severity by upregulating IL‐17 production and increasing the accumulation of effector T cells in joints without affecting Th1/Th2 development.
- 10 July 2008
- Published by Wiley in Immunology
- Vol. 124 (4) , 503-513
Open AccessDistinct in vivo roles of CD80 and CD86 in the effector T‐cell responses inducing antigen‐induced arthritis
Summary: CD80 and CD86 play a critical role in the initiation of T‐cell responses. However, their role in the in vivo effector CD4+ T‐cell responses has been less extensively investigated. The current studies have examined the functional relevance of CD80 and CD86 in the effector CD4+ T‐cell responses inducing antigen‐induced arthritis. Arthritis was induced in C57BL/6 mice by sensitization to methylated bovine serum albumin (mBSA) on day 0, booster immunization (day 7) and intra‐articular injection of mBSA (day 21). Control or anti‐CD80 and/or anti‐CD86 monoclonal antibodies were administered from day 21 to day 28. Arthritis severity and immune responses were assessed on day 28. The development of arthritis was significantly suppressed by inhibition of CD80 or CD86. Blockade of both CD80 and CD86 caused a trend towards reduced disease severity compared to control antibody‐treated mice. Neutralization of CD80 attenuated accumulation of CD4+ T cells in joints and enhanced splenocyte production and circulating levels of interleukin‐4. Inhibition of CD86 or both CD80 and CD86 reduced T‐cell accumulation in joints without affecting T helper type 1/type 2 (Th1/Th2) differentiation or antibody levels. Blockade of CD86, and not CD80, significantly suppressed splenocyte interleukin‐17 (IL‐17) production. These results provide further in vivo evidence that CD80 and CD86 play important pathogenic roles in effector T‐cell responses. CD80 exacerbates arthritis by downregulating systemic levels of IL‐4 and increasing T‐cell accumulation in joints without affecting IL‐17 production. CD86 enhances disease severity by upregulating IL‐17 production and increasing the accumulation of effector T cells in joints without affecting Th1/Th2 development.
- Open Access
- 1 March 2008
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (3) , 477-485
T-bet Deficiency Attenuates Renal Injury in Experimental Crescentic Glomerulonephritis
T-bet is a transcription factor that is essential for T helper (Th)1 lineage commitment and optimal IFN-γ production by CD4+ T cells. We examined the role of T-bet in the development of experimental crescentic glomerulonephritis, which is induced by Th1-predominant, delayed-type hypersensitivity-like responses directed against a nephritogenic antigen. Anti-glomerular basement membrane (GBM) glomerulonephritis was induced in T-bet−/− and wild-type C57BL/6 mice. Compared with wild-type controls, renal injury was attenuated in T-bet−/− mice with glomerulonephritis, evidenced by less proteinuria, glomerular crescents, and tubulointerstitial inflammation. Accumulation of glomerular CD4+ T cells and macrophages was decreased, and was associated with reduced intrarenal expression of the potent Th1 chemoattractants CCL5/RANTES and CXCL9/Mig. Supporting the pro-inflammatory nature of T-bet signaling, assessment of systemic immunity confirmed that T-bet−/− mice had a reduction in Th1 immunity. The kinetic profile of T-bet mRNA in wild-type mice supported the hypothesis that T-bet deficiency attenuates renal injury in part by shifting the Th1/Th2 balance away from a Th1 phenotype. Expression of renal and splenic IL-17A, characteristically expressed by the Th17 subset of effector T cells, which have been implicated in the pathogenesis of autoimmune disease, was increased in T-bet−/− mice. We conclude that T-bet directs Th1 responses that induce renal injury in experimental crescentic glomerulonephritis.
- 1 March 2008
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (3) , 477-485
Open AccessT-bet Deficiency Attenuates Renal Injury in Experimental Crescentic Glomerulonephritis
T-bet is a transcription factor that is essential for T helper (Th)1 lineage commitment and optimal IFN-γ production by CD4+ T cells. We examined the role of T-bet in the development of experimental crescentic glomerulonephritis, which is induced by Th1-predominant, delayed-type hypersensitivity-like responses directed against a nephritogenic antigen. Anti-glomerular basement membrane (GBM) glomerulonephritis was induced in T-bet−/− and wild-type C57BL/6 mice. Compared with wild-type controls, renal injury was attenuated in T-bet−/− mice with glomerulonephritis, evidenced by less proteinuria, glomerular crescents, and tubulointerstitial inflammation. Accumulation of glomerular CD4+ T cells and macrophages was decreased, and was associated with reduced intrarenal expression of the potent Th1 chemoattractants CCL5/RANTES and CXCL9/Mig. Supporting the pro-inflammatory nature of T-bet signaling, assessment of systemic immunity confirmed that T-bet−/− mice had a reduction in Th1 immunity. The kinetic profile of T-bet mRNA in wild-type mice supported the hypothesis that T-bet deficiency attenuates renal injury in part by shifting the Th1/Th2 balance away from a Th1 phenotype. Expression of renal and splenic IL-17A, characteristically expressed by the Th17 subset of effector T cells, which have been implicated in the pathogenesis of autoimmune disease, was increased in T-bet−/− mice. We conclude that T-bet directs Th1 responses that induce renal injury in experimental crescentic glomerulonephritis.
- 16 October 2007
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 29 (4) , 355-374
Leukocytes in glomerular injury
Leukocytes of the innate immune system play a central protective role in immune defense to pathogens but may also mediate injurious inflammatory responses resulting in tissue injury. These leukocytes provide the first rapid cellular defense mechanisms through a limited repertoire of rapid pre-programmed responses, but they are also involved in chronic inflammation and tissue repair. They are directed to sites of pathogen challenge and inflammation by a variety of mechanisms and are activated in response to both exogenous and endogenous stimuli. They do not show the capacity of self–non-self discrimination and memory, which are defining characteristics of the adaptive immune system, although macrophages in particular may show some capacity for differentiation of their effector responses. However, they do play an integral role in adaptive immune responses by their capacity to present antigen, modify T-cell development, and function as effectors of adaptive cell-mediated immunity.
- 16 October 2007
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 29 (4) , 355-374
Leukocytes in glomerular injury
Leukocytes of the innate immune system play a central protective role in immune defense to pathogens but may also mediate injurious inflammatory responses resulting in tissue injury. These leukocytes provide the first rapid cellular defense mechanisms through a limited repertoire of rapid pre-programmed responses, but they are also involved in chronic inflammation and tissue repair. They are directed to sites of pathogen challenge and inflammation by a variety of mechanisms and are activated in response to both exogenous and endogenous stimuli. They do not show the capacity of self–non-self discrimination and memory, which are defining characteristics of the adaptive immune system, although macrophages in particular may show some capacity for differentiation of their effector responses. However, they do play an integral role in adaptive immune responses by their capacity to present antigen, modify T-cell development, and function as effectors of adaptive cell-mediated immunity.
- Open Access
- 1 July 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (7) , 1940-1949
Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis
Most humans with microscopic polyarteritis and anti-myeloperoxidase (anti-MPO), anti-neutrophil cytoplasmic antibodies (ANCA) develop “pauci-immune” crescentic glomerulonephritis. For dissection of the roles of ANCA and cell-mediated effectors in microscopic polyarteritis, experimental autoimmune anti-MPO glomerulonephritis was induced by immunizing C57BL/6 mice with human MPO. Autoimmunity to mouse MPO (ANCA and CD4+ cell reactivity) was induced. Challenge with anti–glomerular basement membrane globulin resulted in accumulation of neutrophils, CD4+ cells and macrophages, and significant numbers of crescentic glomeruli compared with similarly challenged control-immunized mice. MPO-deficient (Mpo−/−) mice immunized with MPO developed similar immune responses to MPO but failed to recruit effector cells to glomeruli or develop significant crescent formation, suggesting that MPO is acting as a planted glomerular autoantigen. Effector CD4+ cell depletion in this model attenuated crescentic glomerulonephritis and effector cell influx without altering ANCA titers. However, B cell–deficient mice, with no ANCA, still developed severe crescentic glomerulonephritis with accumulation of effector cells. Intravital microscopy studies demonstrated that passive transfer of sera from MPO-immunized Mpo−/− mice to LPS-primed mice rapidly induced glomerular neutrophil accumulation and release of MPO. These studies provide in vivo evidence in a relevant vascular bed for both humoral and cellular anti-MPO responses as key inducers of injury. ANCA induces glomerular neutrophil infiltration and MPO deposition. Subsequently, anti-MPO CD4+ cells recognize MPO as a planted glomerular antigen and act with macrophages to amplify severe glomerular injury.
- 1 July 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (7) , 1940-1949
Open AccessAnti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis
Most humans with microscopic polyarteritis and anti-myeloperoxidase (anti-MPO), anti-neutrophil cytoplasmic antibodies (ANCA) develop “pauci-immune” crescentic glomerulonephritis. For dissection of the roles of ANCA and cell-mediated effectors in microscopic polyarteritis, experimental autoimmune anti-MPO glomerulonephritis was induced by immunizing C57BL/6 mice with human MPO. Autoimmunity to mouse MPO (ANCA and CD4+ cell reactivity) was induced. Challenge with anti–glomerular basement membrane globulin resulted in accumulation of neutrophils, CD4+ cells and macrophages, and significant numbers of crescentic glomeruli compared with similarly challenged control-immunized mice. MPO-deficient (Mpo−/−) mice immunized with MPO developed similar immune responses to MPO but failed to recruit effector cells to glomeruli or develop significant crescent formation, suggesting that MPO is acting as a planted glomerular autoantigen. Effector CD4+ cell depletion in this model attenuated crescentic glomerulonephritis and effector cell influx without altering ANCA titers. However, B cell–deficient mice, with no ANCA, still developed severe crescentic glomerulonephritis with accumulation of effector cells. Intravital microscopy studies demonstrated that passive transfer of sera from MPO-immunized Mpo−/− mice to LPS-primed mice rapidly induced glomerular neutrophil accumulation and release of MPO. These studies provide in vivo evidence in a relevant vascular bed for both humoral and cellular anti-MPO responses as key inducers of injury. ANCA induces glomerular neutrophil infiltration and MPO deposition. Subsequently, anti-MPO CD4+ cells recognize MPO as a planted glomerular antigen and act with macrophages to amplify severe glomerular injury.
- 1 August 2005
- Published by Elsevier in Kidney International
- Vol. 68 (2) , 584-594
CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms
- 1 August 2005
- Published by Elsevier in Kidney International
- Vol. 68 (2) , 584-594
CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms